Drug Discovery Collaborations

News Drug Discovery Collaborations

• Fundación MEDINA Announces Drug Discovery Collaboration with Cubist Pharmaceuticals, Inc.

  Fundación MEDINA (Fundación Centro de Excelencia en Investigación de Medicamentos Innovadores en Andalucía), a research organization focused on discovery of drugs and bioactive molecules from natural products, announced a contract research collaboration with Cubist Pharmaceuticals to discover antibi more

• NovAliX Enters into Multi-Target Integrated Drug Discovery Collaboration with Teijin Pharma

  NovAliX SAS announced that it has entered into a multi-target integrated drug discovery collaboration with Teijin Pharma Limited of Tokyo, Japan.Within the alliance the companies will collaborate to develop novel drug candidates against multiple targets across different therapeutic areas. NovAliX wi more

• Evotec announces second multi-target collaboration with UCB

  Evotec AG announced that it has entered into a second multi year, multi target integrated drug discovery collaboration with UCB in the field of immunology.As part of the collaboration, Evotec will apply their integrated drug discovery expertise and technologies to identify interesting small molecule more

Market studies Drug Discovery Collaborations

• CrystalGenomics, Inc. (083790) - Financial and Strategic SWOT Analysis Review

  CrystalGenomics, Inc. (CrystalGenomics) is a publicly held pharmaceutical company engaged in the structure-based drug discovery and development of vaccines to several diseases. It also offers structure determination research, and biotechnology services to the pharmaceutical industry. The company has more

• Dr. Reddy's Laboratories Limited (DRREDDY) - Financial and Strategic SWOT Analysis Review

  Dr. Reddy’s Laboratories Limited (RL) is one of the leading pharmaceutical company. The company operates through three reportable business segments namely,Pharmaceutical Services and Active Ingredients (PSAI), Global Generics and Proprietary products. It serves the medical needs of the individuals t more

• Galapagos NV (GLPG) - Financial and Strategic SWOT Analysis Review

  Galapagos NV (Galapagos) is Belgium based health care pharmaceutical company. The company is involved in discovery and manufactures of disease modifying drugs. It develops GLPG0259 which aim protein kinase MAPKAPK5, as its leading drug candidate for the under initial stages of clinical trials. The more

Websites Drug Discovery Collaborations